Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry

There appears to be considerable interaction between CPG authors and the pharmaceutical industry, and the need for appropriate disclosure of financial conflicts of interest for authors of CPGs and a formal process for discussing these conflicts prior to CPG development is highlighted.

Abstract

Although the response rate for this survey was low, there appears to be considerable interaction between CPG authors and the pharmaceutical industry. Our study highlights the need for appropriate disclosure of financial conflicts of interest for authors of CPGs and a formal process for discussing these conflicts prior to CPG development.